We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-6.78%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$291M
AUM Growth
-$38.7M
Cap. Flow
-$14.6M
Cap. Flow %
-5.02%
Top 10 Hldgs %
61.24%
Holding
33
New
4
Increased
8
Reduced
15
Closed
3

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$12.1M
2
PFE icon
Pfizer
PFE
+$9.09M
3
AMGN icon
Amgen
AMGN
+$8.9M
4
CNC icon
Centene
CNC
+$4.68M
5
ELAN icon
Elanco Animal Health
ELAN
+$3.62M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$13.2M
2
GILD icon
Gilead Sciences
GILD
+$8.25M
3
BAX icon
Baxter International
BAX
+$7.62M
4
GEHC icon
GE HealthCare
GEHC
+$4.82M
5
CVS icon
CVS Health
CVS
+$4.77M

Sector Composition

Rank Sector Weight
1 Healthcare 99.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
1
Pfizer
PFE
$143B
$30.6M 10.53%
1,155,000
+335,000
+41% +$9.09M
MDT icon
2
Medtronic
MDT
$106B
$25.6M 8.79%
320,000
-14,890
-4% -$1.29M
BMY icon
3
Bristol-Myers Squibb
BMY
$124B
$20.7M 7.12%
366,166
-235,834
-39% -$13.2M
GILD icon
4
Gilead Sciences
GILD
$167B
$18.2M 6.27%
197,500
-91,663
-32% -$8.25M
BDX icon
5
Becton Dickinson
BDX
$43.6B
$17.2M 5.93%
76,000
-1,280
-2% -$296K
ZBH icon
6
Zimmer Biomet
ZBH
$17.6B
$14.5M 5%
137,714
+31,714
+30% +$3.4M
BMRN icon
7
BioMarin Pharmaceuticals
BMRN
$11.5B
$14.3M 4.91%
217,348
+27,000
+14% +$1.81M
INCY icon
8
Incyte
INCY
$23.4B
$13.6M 4.69%
197,400
-61,600
-24% -$4.39M
AMGN icon
9
Amgen
AMGN
$198B
$12M 4.12%
46,000
+30,000
+188% +$8.9M
JNJ icon
10
Johnson & Johnson
JNJ
$609B
$11.3M 3.88%
+78,000
New +$12.1M
CAH icon
11
Cardinal Health
CAH
$53.5B
$10.4M 3.58%
88,000
-29,098
-25% -$3.4M
CNC icon
12
Centene
CNC
$32.8B
$10.3M 3.54%
170,000
+75,000
+79% +$4.68M
CVS icon
13
CVS Health
CVS
$137B
$9.74M 3.35%
217,000
-85,000
-28% -$4.77M
BRKR icon
14
Bruker
BRKR
$8.86B
$9.32M 3.2%
158,970
– –
QGEN icon
15
Qiagen
QGEN
$8.49B
$9.08M 3.12%
198,327
-18,599
-9% -$833K
IONS icon
16
Ionis Pharmaceuticals
IONS
$8.99B
$8.25M 2.83%
235,842
+25,000
+12% +$934K
EW icon
17
Edwards Lifesciences
EW
$49.4B
$7.33M 2.52%
99,000
-7,153
-7% -$501K
ELV icon
18
Elevance Health
ELV
$80.9B
$6.37M 2.19%
17,279
-9,000
-34% -$3.77M
BIO icon
19
Bio-Rad Laboratories Class A
BIO
$8.15B
$5.53M 1.9%
16,829
– –
BAX icon
20
Baxter International
BAX
$11.7B
$4.63M 1.59%
158,650
-226,350
-59% -$7.62M
BNTX icon
21
BioNTech
BNTX
$23.1B
$4.56M 1.57%
40,000
– –
BIIB icon
22
Biogen
BIIB
$30.4B
$4.43M 1.52%
29,000
-6,166
-18% -$1.04M
GEHC icon
23
GE HealthCare
GEHC
$28.7B
$3.91M 1.34%
50,000
-56,700
-53% -$4.82M
HUM icon
24
Humana
HUM
$48B
$3.55M 1.22%
14,000
+2,000
+17% +$536K
ELAN icon
25
Elanco Animal Health
ELAN
$12.9B
$3.35M 1.15%
+276,907
New +$3.62M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2024 Portfolio in Review

As of Q4 2024, Sector Gamma AS held 33 positions worth $291M, down 12% from $330M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Sector Gamma AS withdrew a net $14.6M in Q4 2024, closing 3 positions and reducing 15 holdings. Its most notable exit was Universal Health Services, an estimated $4.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Johnson & Johnson worth $11.3M.

  • Sector Gamma AS's largest Q4 2024 buy was Johnson & Johnson: 78,000 shares worth $11.3M.
  • Sector Gamma AS added most to Pfizer in Q4 2024, an estimated $9.09M increase.
  • Sector Gamma AS's biggest Q4 2024 reduction was Bristol-Myers Squibb, cutting an estimated $13.2M.
  • Sector Gamma AS fully exited Universal Health Services in Q4 2024, selling an estimated $4.04M.
  • Sector Gamma AS's ten largest holdings make up 61% of its $291M portfolio in Q4 2024.
  • Sector Gamma AS opened 4 new positions and closed 3 in Q4 2024.
  • Sector Gamma AS's portfolio value fell 12% quarter-over-quarter to $291M.

Based on Sector Gamma AS's 13F filing for Q4 2024, filed 11 Feb 2025.